Newsletter | July 9, 2019

07.09.19 -- Laboratory Testing Of Known Compounds For Cancer Treatment Efficacy

Featured Editorial
Risk Assessment Of Objectionable Microorganisms In Nonsterile Pharmaceuticals
By Crystal M. Booth, PSC Biotech

This is Part 2 of a two-part article on objectionable microorganisms in the nonsterile microbiology industry It discusses a risk-based approach to determine if a microorganism is objectionable for an application.

Industry Insights
The Impact Of PM2.5 Beyond Respiratory Health
White Paper | GE Healthcare Life Sciences

Although it is still challenging to gauge the full extent of the consequences of air pollution, governments around the world are starting to recognize the seriousness of this problem, introducing measures to curb pollution. However, considerable progress is still needed, and PM2.5 particles (those ≤2.5 µm) are of particular concern, not just in respiratory health but in a wider context.

Personalized Healthcare Is Better Healthcare
Dassault Systemes Americas
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.